Latest Financials News

Scorpion Minerals Limited has had its trading suspension lifted following an announcement about a potential joint venture and capital raising, signaling renewed market activity.

Ecofibre Limited has restructured its Australian loan facilities, extending repayment terms and adjusting interest rates to support a more sustainable financial footing.

E79 Gold Mines has entered a strategic earn-in and joint venture agreement with Scorpion Minerals over the Jungar Flats Project, enabling E79 to reduce expenditure while focusing on promising gold and copper-gold projects elsewhere.

WAM Capital has reported a robust 14.9% increase in its investment portfolio over six months, outperforming key ASX indices and maintaining its interim dividend at 7.75 cents per share.

BSA Limited has temporarily paused trading of its securities, signaling potential significant developments. Investors await further details to understand the implications.

Microequities Asset Management Group Limited has reported a robust 46.4% increase in profit after tax for the half-year ended December 2024, alongside a record $650 million in Funds Under Management and a raised interim dividend.

Westgold Resources reported a 72% jump in revenue to $624 million in H1 FY25, driven by increased gold production and higher prices, but posted a net loss after tax due to significant one-off acquisition expenses.

Pengana Capital Group reports a rise in Funds Under Management to $3.64 billion as of January 31, 2025, following significant distributions to investors. The firm’s half-year audited results are due next month, setting the stage for further insights.

WAM Capital Limited has delivered a robust half-year performance ending December 2024, posting a 40% increase in net profit and declaring a steady interim dividend of 7.75 cents per share. The company’s investment portfolio outperformed key ASX indices, underpinning strong shareholder returns.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

LGI Limited reports a solid H1 FY25 performance with modest revenue growth and increased EBITDA, driven by expanded biogas flows and carbon abatement activities. The company confirms a positive outlook with a 12-15% underlying EBITDA growth forecast for FY25.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.